80 years of clinical experience meet neurobiological precision – the keynote speakers of the Biomarker Workshop 2025
When two of the world’s leading autism experts combine insights from eight decades of clinical practice with the latest neurobiological research, something extraordinary emerges. On 11 December 2025, Professor Tony Attwood and Dr Michelle Garnett will join live from Australia to present their keynote at the Biomarker Workshop in Zurich.

From Brisbane to the Biomarker Workshop: why this live connection matters
In 2019, Attwood and Garnett jointly founded “Attwood & Garnett Events” with the vision of fostering a neuro-affirming community Attwood & Garnett Events. More than 100,000 participants worldwide have already benefited from their workshops – parents, educators and professionals who have transformed their practice.

Their keynote on 11 December at the Biomarker Workshop is not a theoretical lecture. It is the synthesis of 80 years of clinical experience, translated into practical insights into how objective neurobiological markers can make visible precisely those “hidden presentations” that traditional behaviour-based diagnostics overlooks.
The invisible diagnoses: a global problem with local consequences
Almost 80% of autistic women remain undiagnosed by the age of 18 – an alarming statistic that has occupied Tony Attwood and Michelle Garnett for decades. While boys are diagnosed at an average age of 8, girls often have to wait until the age of 13. These five years of delay are not just lost time – they are five years of misdiagnoses, ineffective treatments and the painful feeling of being “different” without understanding why.
Michelle Garnett’s research on the female autism profile has fundamentally changed our understanding. Her influential work “Spectrum Women: Walking to the Beat of Autism” (2018) became a milestone, documenting systematically for the first time how masking strategies can lead to decades of misdiagnosis. These “hidden presentations” are exactly the topic of their keynote on 11 December.
Why “Beyond the Stereotypes” is more than a talk title
The keynote “Beyond the Stereotypes: Biomarkers for the Hidden Presentations of Autism, ADHD, and Anxiety – Insights from 80 Years of Clinical Practice” brings together three revolutionary perspectives:
1. Clinical depth that only decades can create
Professor Tony Attwood brings five decades of specialisation in autism. His ground-breaking book “Asperger’s Syndrome: A Guide for Parents and Professionals” (1998) has been translated into more than 25 languages and shaped an entire generation of professionals. Dr Michelle Garnett contributes more than 30 years of clinical experience, combined with her role as founder and long-standing clinical director of Minds & Hearts, a clinic specialising in autism.
2. Lived experience meets scientific expertise
What makes Michelle Garnett unique: she herself is a late-diagnosed AuDHDer – she lives with the combination of autism and ADHD. This dual perspective – as a clinician and as someone with lived experience – gives her work an authenticity and depth that is rare in the professional world. She understands not only in theory but from personal experience how camouflaging works, what price it exacts and why objective biomarkers are so urgently needed.
3. Research that changes practice
Garnett’s peer-reviewed research has decisively shaped our understanding of early autism identification, the female autism profile and the link between mental health and positive outcomes in autistic people. Together, Attwood and Garnett have published more than 50 peer-reviewed papers and written 16 books that now train other clinicians.

From Brisbane to Zurich: why this workshop matters
In 2019, Attwood and Garnett jointly founded “Attwood & Garnett Events” with the vision of fostering a neuro-affirming community. More than 100,000 participants worldwide have already benefited from their workshops – parents, educators and professionals who have transformed their practice.
Their keynote on 11 December in Zurich is not a theoretical lecture. It is the synthesis of 80 years of clinical experience, translated into practical insights into how objective neurobiological markers can make visible precisely those “hidden presentations” that traditional behaviour-based diagnostics overlooks.
The key questions they will answer:
- How do the neurobiological profiles of women and men with autism, ADHD and anxiety differ?
- Why do classic stereotypes lead to systematic misdiagnoses?
- Which biomarkers can objectively capture “masked” presentations?
- How do we integrate clinical intuition with neurobiological precision?
The big picture: from stereotypes to personalised interventions
In their critical analysis of the ADOS (Autism Diagnostic Observation Schedule), Attwood and Garnett show that only 24% of clinicians achieve “good” or “excellent” diagnostic agreement when trained to clinical standard. Inter-rater agreement for diagnostic status is only 33% – alarmingly low for a supposed “gold standard” instrument.
This diagnostic uncertainty has real consequences: delayed correct diagnoses, ineffective treatment attempts, secondary psychological distress. This is where objective biomarkers come in – not as a replacement for clinical expertise, but as a complement that creates precision where subjective assessment reaches its limits.
Attwood and Garnett’s vision is clear: knowledge combined with optimism and respect leads to optimal outcomes for autistic children, adolescents, adults, students, employees and partners. The Biomarker Workshop 2025 makes this vision practically achievable.
Why you should not miss this keynote
On 11 December at 10.00 am you will witness a rare moment: two pioneers of autism research, who together have more clinical experience than most teams, share their insights into how neurobiologically oriented diagnostics can close the gap between stereotypes and individual reality.
Participants describe their workshops as “more than a conference – a lived experience, a treasured memory that not only inspires but empowers”. Another voice: “Tony and Michelle are by far the world’s leading experts on autism/ADHD and have a unique presentation style.”
What you will concretely take away:
- Practical strategies for recognising masked presentations of autism, ADHD and anxiety
- Evidence-based diagnostics that go beyond classic behavioural observation
- Differential diagnostic tools for complex comorbidities
- Integrating “neuro-affirming practice” with objective diagnostics
The workshop as a turning point
The Biomarker Workshop 2025 marks a paradigm shift – from behaviour-based stereotypes to the integration of behaviour, thinking, emotions and biology. Attwood and Garnett’s keynote opens a day full of practical implementations of this vision:
- 09:15: Andreas Müller shows practical biomarker applications
- 11:30: Nicole Chou explores PDA profiles
- 13:30: Silvana Markovska and Alexander Tenev demonstrate neurophysiological implementation
- 14:15: Matthias Huber speaks about lived experience as a therapeutic advantage
- 15:30: Corinne Henzen presents the neurobiological foundations of hypersensitivity
- 16:15: Birgit Graf shows integration into child and adolescent psychiatry
Your participation: on site or hybrid
Date: Thursday, 11 December 2025
Time: 9.00 am–5.30 pm
Venue: Paulus Akademie, Pfingstweidstrasse 28, 8005 Zurich
Format: Hybrid (limited places on site, unlimited online)
Cost: CHF 150
Credits: 7 CPD credits
Language: German (Attwood/Garnett via video, Markovska/Tenev in English)
Target audience: Psychiatrists, neurologists, neuropaediatricians, paediatricians, psychotherapists, psychologists
Register now and be part of the change
The diagnostic uncertainty from which thousands of patients suffer is not an inevitable fate. Complementary objectifying markers offer a path to more precise, personalised diagnostics – and thus to better outcomes.
If you want to understand how 80 years of clinical experience merge with cutting-edge neurobiology to shape the future of psychiatric diagnostics – then this workshop is for you.
About the speakers:
Professor Tony Attwood is Adjunct Professor at Griffith University in Queensland and one of the world’s leading autism specialists, with more than 50 years of experience. Dr Michelle Garnett is a clinical psychologist with more than 30 years of specialisation in autism, co-founder of Attwood & Garnett Events and herself an AuDHDer.
Organised by: Brain and Trauma Foundation Grison (GTSG)
Director: Dr Andreas Müller
This article is the first in our speaker series on the Biomarker Workshop 2025. In the coming weeks we will introduce all the speakers and show how their expertise contributes to a comprehensive understanding of ADHD, autism, anxiety and hypersensitivity.
